HERON THERAPEUTICS, INC. /DE/ (HRTX) Corporate Subsidiaries
HERON THERAPEUTICS, INC. /DE/ (HRTX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: HRTX
CIK: 818033
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
WithumSmith+Brown, PC
Auditor SinceSince 12/31/2021 12:00:00 AM
Lead Engagement PartnerJason Seifert
Audit LocationOrlando, Florida, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-29 | 2026-09-23 | 8-K | 0001193125-26-407728 | View SEC Doc Filr Page |
| 8-K | 2026-08-14 | 2026-08-13 | 8-K | 0001193125-26-352403 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-06 | 4 | 0001193125-26-341528 | View SEC Doc Filr Page |
| 10-Q | 2026-08-10 | 2026-06-30 | 10-Q | 0001193125-26-341301 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | 8-K | 0001193125-26-341300 | View SEC Doc Filr Page |
| 4 | 2026-08-03 | 2026-07-31 | 4 | 0001193125-26-329848 | View SEC Doc Filr Page |
| 4 | 2026-08-03 | 2026-07-30 | 4 | 0001193125-26-329804 | View SEC Doc Filr Page |
| 4 | 2026-08-03 | 2026-07-30 | 4 | 0001193125-26-329720 | View SEC Doc Filr Page |
| 4 | 2026-08-03 | 2026-07-30 | 4 | 0001193125-26-329694 | View SEC Doc Filr Page |
| 4 | 2026-07-20 | 2026-07-19 | 4 | 0001193125-26-308958 | View SEC Doc Filr Page |
| 4 | 2026-07-20 | 2026-07-19 | 4 | 0001193125-26-308922 | View SEC Doc Filr Page |
| 4 | 2026-07-20 | 2026-07-19 | 4 | 0001193125-26-308887 | View SEC Doc Filr Page |
| 8-K | 2026-06-25 | 2026-06-25 | 8-K | 0001193125-26-282988 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-16 | 4 | 0001193125-26-273552 | View SEC Doc Filr Page |
| 8-K | 2026-06-16 | 2026-06-11 | 8-K | 0001193125-26-272388 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-06 | 4 | 0001193125-26-260931 | View SEC Doc Filr Page |
| 8-K | 2026-06-02 | 2026-06-02 | 8-K | 0001193125-26-253851 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-13 | — | SCHEDULE 13G/A Filing | 0000919574-26-002913 | View SEC Doc Filr Page |
| 10-Q | 2026-05-11 | 2026-03-31 | 10-Q | 0001193125-26-215755 | View SEC Doc Filr Page |
| 8-K | 2026-05-11 | 2026-05-11 | 8-K | 0001193125-26-215752 | View SEC Doc Filr Page |
| 4 | 2026-05-07 | 2026-05-06 | 4 | 0001193125-26-211230 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-04-30 | 4 | 0001193125-26-203374 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-04-30 | 4 | 0001193125-26-203344 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-04-30 | 4 | 0001193125-26-203272 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-04-30 | 4 | 0001193125-26-203196 | View SEC Doc Filr Page |